menu
    • menu

    Company profile for XENOPORT INC

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astell...
    XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XENOPORT INCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6 Concourse Pkwy Ste 1800 Atlanta, GA, 30328-5353
    Telephone
    Telephone
    (408) 616-7200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.xenoport.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xenoport/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
    AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer

    16 Feb 2017

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-appoints-vincent-j-angotti-chief-executive-officer-300409117.html

    PR NEWSWIRE
    16 Feb 2017
    Share Share
    Arbor Pharma Shells Out $467 Million for Bay Area’s Restless Leg Drug Company
    Arbor Pharma Shells Out $467 Million for Bay Area’s Restless Leg Drug Company

    23 May 2016

    // Mark Terry BIOSPACE

    http://www.biospace.com/News/arbor-pharma-shells-out-467-million-for-bay-areas/420433/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

    Mark Terry BIOSPACE
    23 May 2016
    Share Share
    Struggling XenoPort rumored to consider a sale
    Struggling XenoPort rumored to consider a sale

    22 Jan 2016

    // Damian Garde FIERCE BIOTECH

    http://www.fiercebiotech.com/story/struggling-xenoport-rumored-consider-sale/2016-01-22

    Damian Garde FIERCE BIOTECH
    22 Jan 2016
    Share Share
    XenoPort hits reset after a psoriasis setback…
    XenoPort hits reset after a psoriasis setback…

    02 Oct 2015

    // Damian Garde FIERCE BIOTECH

    http://www.fiercebiotech.com/story/xenoport-hits-reset-after-psoriasis-setback-cutting-jobs-and-bailing-rd/2015-10-02

    Damian Garde FIERCE BIOTECH
    02 Oct 2015
    Share Share
    Xenoport to seek partner to develop drug; CEO steps down
    Xenoport to seek partner to develop drug; CEO steps down

    01 Oct 2015

    // Rosmi Shaji REUTERS

    http://www.reuters.com/article/2015/10/01/us-xenoport-ceo-idUSKCN0RV5V920151001

    Rosmi Shaji REUTERS
    01 Oct 2015
    Share Share
    XenoPort plunges as investors sour fast on 'positive' psoriasis data
    XenoPort plunges as investors sour fast on 'positive' psoriasis data

    15 Sep 2015

    // John Carroll FIERCE BIOTECH

    http://www.fiercebiotech.com/story/xenoport-says-its-ready-push-psoriasis-pill-phiii-doubts-persist/2015-09-15

    John Carroll FIERCE BIOTECH
    15 Sep 2015
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search